Champions Historical Balance Sheet

CSBR Stock

USD 9.57 0.28 3.01%

Trend analysis of Champions Oncology balance sheet accounts such as Short Long Term Debt Total of 9 M, Other Current Liabilities of 739.7 K or Total Current Liabilities of 26 M provides information on Champions Oncology's total assets, liabilities, and equity, which is the actual value of Champions Oncology to its prevalent stockholders. By breaking down trends over time using Champions Oncology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Champions Oncology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Champions Oncology is a good buy for the upcoming year.

Champions Oncology Inventory

0.86

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Champions Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.

About Champions Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Champions Oncology at a specified time, usually calculated after every quarter, six months, or one year. Champions Oncology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Champions Oncology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Champions currently owns. An asset can also be divided into two categories, current and non-current.

Champions Oncology Balance Sheet Chart

At this time, Champions Oncology's Non Current Assets Total are relatively stable compared to the past year. As of 03/26/2025, Non Currrent Assets Other is likely to grow to about 223.4 K, though Total Stockholder Equity is likely to grow to (2.1 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Champions Oncology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Champions Oncology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Champions Oncology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Champions Oncology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Champions Oncology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Champions Oncology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Champions Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.At this time, Champions Oncology's Non Current Assets Total are relatively stable compared to the past year. As of 03/26/2025, Non Currrent Assets Other is likely to grow to about 223.4 K, though Total Stockholder Equity is likely to grow to (2.1 M).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	8.6M	7.4M	8.5M	9.0M
Total Assets	34.3M	26.1M	30.1M	31.6M

Short Long Term Debt Total Total Assets

Champions Oncology balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Liab	Other Assets
Total Assets		0.96	0.59	0.9	0.23	0.97	0.58	-0.67	0.77	0.39	0.97	-0.27	0.39	0.92	-0.22	0.77	0.8	-0.38	0.91	0.76	0.93	0.88	0.96	-0.22	-0.09	-0.61
Short Long Term Debt Total	0.96		0.57	0.88	0.12	0.99	0.75	-0.6	0.74	0.19	0.99	-0.34	0.2	0.92	-0.33	0.73	0.84	-0.22	0.9	0.69	0.93	0.92	0.85	-0.33	-0.2	-0.68
Other Current Liab	0.59	0.57		0.39	0.39	0.58	0.3	-0.52	0.26	0.33	0.58	-0.36	0.33	0.47	-0.34	0.55	0.49	-0.31	0.31	0.49	0.45	0.38	0.55	-0.34	-0.17	-0.26
Total Current Liabilities	0.9	0.88	0.39		-0.15	0.9	0.71	-0.73	0.96	0.07	0.91	0.02	0.08	0.97	-0.34	0.82	0.7	-0.34	0.88	0.82	0.97	0.95	0.82	-0.34	-0.09	-0.49
Total Stockholder Equity	0.23	0.12	0.39	-0.15		0.11	-0.35	-0.07	-0.33	0.72	0.11	-0.47	0.72	-0.07	0.29	0.03	-0.09	-0.12	0.07	0.09	-0.14	-0.16	0.35	0.29	-0.01	-0.19
Property Plant And Equipment Net	0.97	0.99	0.58	0.9	0.11		0.76	-0.65	0.76	0.18	1.0	-0.33	0.18	0.94	-0.37	0.78	0.83	-0.24	0.91	0.73	0.94	0.92	0.86	-0.37	-0.19	-0.64
Net Debt	0.58	0.75	0.3	0.71	-0.35	0.76		-0.49	0.63	-0.5	0.75	-0.14	-0.5	0.78	-0.6	0.62	0.6	0.09	0.66	0.53	0.72	0.81	0.34	-0.6	-0.27	-0.44
Retained Earnings	-0.67	-0.6	-0.52	-0.73	-0.07	-0.65	-0.49		-0.69	-0.07	-0.67	-0.17	-0.07	-0.75	0.34	-0.94	-0.35	0.64	-0.59	-0.96	-0.66	-0.61	-0.63	0.34	0.14	0.0
Accounts Payable	0.77	0.74	0.26	0.96	-0.33	0.76	0.63	-0.69		-0.01	0.77	0.19	-0.01	0.89	-0.29	0.76	0.59	-0.36	0.76	0.77	0.91	0.9	0.71	-0.29	-0.04	-0.41
Cash	0.39	0.19	0.33	0.07	0.72	0.18	-0.5	-0.07	-0.01		0.18	-0.3	1.0	0.02	0.44	0.03	0.21	-0.4	0.19	0.1	0.13	-0.02	0.6	0.44	0.13	-0.22
Non Current Assets Total	0.97	0.99	0.58	0.91	0.11	1.0	0.75	-0.67	0.77	0.18		-0.3	0.18	0.95	-0.36	0.79	0.83	-0.27	0.91	0.75	0.95	0.92	0.87	-0.36	-0.18	-0.63
Non Currrent Assets Other	-0.27	-0.34	-0.36	0.02	-0.47	-0.33	-0.14	-0.17	0.19	-0.3	-0.3		-0.3	-0.06	0.16	0.06	-0.34	-0.41	-0.17	0.19	-0.1	-0.03	-0.22	0.16	0.24	0.54
Cash And Short Term Investments	0.39	0.2	0.33	0.08	0.72	0.18	-0.5	-0.07	-0.01	1.0	0.18	-0.3		0.02	0.44	0.03	0.21	-0.4	0.2	0.1	0.13	-0.02	0.6	0.44	0.13	-0.22
Net Receivables	0.92	0.92	0.47	0.97	-0.07	0.94	0.78	-0.75	0.89	0.02	0.95	-0.06	0.02		-0.38	0.87	0.72	-0.31	0.91	0.83	0.96	0.96	0.81	-0.38	-0.1	-0.51
Common Stock Total Equity	-0.22	-0.33	-0.34	-0.34	0.29	-0.37	-0.6	0.34	-0.29	0.44	-0.36	0.16	0.44	-0.38		-0.34	-0.22	-0.16	-0.24	-0.27	-0.33	-0.31	-0.04	1.0	0.33	0.2
Common Stock Shares Outstanding	0.77	0.73	0.55	0.82	0.03	0.78	0.62	-0.94	0.76	0.03	0.79	0.06	0.03	0.87	-0.34		0.5	-0.54	0.7	0.97	0.78	0.75	0.7	-0.34	-0.15	-0.15
Non Current Liabilities Total	0.8	0.84	0.49	0.7	-0.09	0.83	0.6	-0.35	0.59	0.21	0.83	-0.34	0.21	0.72	-0.22	0.5		-0.28	0.75	0.4	0.84	0.75	0.71	-0.22	-0.07	-0.56
Inventory	-0.38	-0.22	-0.31	-0.34	-0.12	-0.24	0.09	0.64	-0.36	-0.4	-0.27	-0.41	-0.4	-0.31	-0.16	-0.54	-0.28		-0.29	-0.6	-0.35	-0.21	-0.48	-0.16	-0.29	-0.24
Other Current Assets	0.91	0.9	0.31	0.88	0.07	0.91	0.66	-0.59	0.76	0.19	0.91	-0.17	0.2	0.91	-0.24	0.7	0.75	-0.29		0.69	0.9	0.89	0.85	-0.24	-0.06	-0.6
Other Stockholder Equity	0.76	0.69	0.49	0.82	0.09	0.73	0.53	-0.96	0.77	0.1	0.75	0.19	0.1	0.83	-0.27	0.97	0.4	-0.6	0.69		0.74	0.73	0.72	-0.27	-0.12	-0.13
Total Liab	0.93	0.93	0.45	0.97	-0.14	0.94	0.72	-0.66	0.91	0.13	0.95	-0.1	0.13	0.96	-0.33	0.78	0.84	-0.35	0.9	0.74		0.95	0.84	-0.33	-0.09	-0.55
Property Plant And Equipment Gross	0.88	0.92	0.38	0.95	-0.16	0.92	0.81	-0.61	0.9	-0.02	0.92	-0.03	-0.02	0.96	-0.31	0.75	0.75	-0.21	0.89	0.73	0.95		0.76	-0.31	-0.12	-0.62
Total Current Assets	0.96	0.85	0.55	0.82	0.35	0.86	0.34	-0.63	0.71	0.6	0.87	-0.22	0.6	0.81	-0.04	0.7	0.71	-0.48	0.85	0.72	0.84	0.76		-0.04	0.0	-0.55
Common Stock	-0.22	-0.33	-0.34	-0.34	0.29	-0.37	-0.6	0.34	-0.29	0.44	-0.36	0.16	0.44	-0.38	1.0	-0.34	-0.22	-0.16	-0.24	-0.27	-0.33	-0.31	-0.04		0.33	0.2
Other Liab	-0.09	-0.2	-0.17	-0.09	-0.01	-0.19	-0.27	0.14	-0.04	0.13	-0.18	0.24	0.13	-0.1	0.33	-0.15	-0.07	-0.29	-0.06	-0.12	-0.09	-0.12	0.0	0.33		0.07
Other Assets	-0.61	-0.68	-0.26	-0.49	-0.19	-0.64	-0.44	0.0	-0.41	-0.22	-0.63	0.54	-0.22	-0.51	0.2	-0.15	-0.56	-0.24	-0.6	-0.13	-0.55	-0.62	-0.55	0.2	0.07

Click cells to compare fundamentals

Champions Oncology Account Relationship Matchups

Champions Oncology balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	27.6M	35.4M	34.3M	26.1M	30.1M	31.6M
Short Long Term Debt Total	9.6M	9.5M	8.6M	7.4M	8.5M	9.0M
Other Current Liab	2.2M	1.4M	1.2M	973K	1.1M	739.7K
Total Current Liabilities	11.2M	17.5M	21.7M	21.5M	24.8M	26.0M
Total Stockholder Equity	7.4M	9.1M	4.6M	(1.9M)	(2.2M)	(2.1M)
Property Plant And Equipment Net	14.6M	15.4M	14.5M	12.0M	13.8M	14.5M
Net Debt	4.9M	459K	(1.5M)	4.8M	4.3M	4.5M
Retained Earnings	(72.5M)	(72.0M)	(77.3M)	(84.6M)	(76.1M)	(72.3M)
Accounts Payable	1.9M	2.9M	5.3M	5.8M	6.7M	7.0M
Cash	4.7M	9.0M	10.1M	2.6M	3.0M	3.7M
Non Current Assets Total	15.0M	15.7M	14.9M	12.5M	14.4M	15.1M
Cash And Short Term Investments	4.7M	9.0M	10.1M	2.6M	3.0M	3.7M
Net Receivables	7.0M	9.5M	8.0M	9.5M	11.0M	11.5M
Common Stock Shares Outstanding	14.6M	14.2M	13.5M	13.5M	15.6M	16.4M
Liabilities And Stockholders Equity	27.6M	35.4M	34.3M	26.1M	30.1M	31.6M
Non Current Liabilities Total	9.0M	8.8M	7.9M	6.5M	7.5M	7.8M
Other Current Assets	957K	2.3M	1.3M	1.5M	1.7M	1.8M
Other Stockholder Equity	79.9M	81.1M	81.9M	82.7M	95.1M	99.8M
Total Liab	20.2M	26.3M	29.7M	28.0M	32.2M	33.9M
Property Plant And Equipment Gross	14.6M	15.4M	14.5M	22.4M	25.7M	27.0M
Total Current Assets	12.6M	19.7M	19.5M	13.6M	15.7M	16.5M
Other Liab	178K	181K	391K	551K	633.7K	500.9K
Short Term Debt	818K	2.1M	2.4M	2.7M	3.1M	3.2M
Property Plant Equipment	6.8M	14.6M	15.4M	14.5M	16.7M	17.5M
Current Deferred Revenue	6.3M	11.1M	12.8M	12.1M	13.9M	14.6M
Retained Earnings Total Equity	(72.7M)	(72.5M)	(72.0M)	(77.3M)	(69.6M)	(73.1M)
Net Tangible Assets	5.0M	7.1M	8.8M	4.3M	4.9M	3.9M
Capital Surpluse	78.0M	79.9M	81.1M	82.0M	94.3M	77.6M

Pair Trading with Champions Oncology

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Champions Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will appreciate offsetting losses from the drop in the long position's value.

Moving together with Champions Stock

0.61

DMAC

DiaMedica Therapeutics

Pair Corr

Moving against Champions Stock

0.63	DSGN	Design Therapeutics	Pair Corr
0.4	VERA	Vera Therapeutics	Pair Corr
0.35	CDIOW	Cardio Diagnostics	Pair Corr

The ability to find closely correlated positions to Champions Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Champions Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Champions Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Champions Oncology to buy it.

The correlation of Champions Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Champions Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Champions Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Champions Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Champions Stock Analysis

When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Champions Historical Balance Sheet

Champions Oncology Inventory

0.86

About Champions Balance Sheet Analysis

Champions Oncology Balance Sheet Chart

Total Assets

Total Current Liabilities

Champions Oncology balance sheet Correlations

Champions Oncology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Champions Oncology balance sheet Accounts

Pair Trading with Champions Oncology

Moving together with Champions Stock

Moving against Champions Stock

Additional Tools for Champions Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Net	+ 0.97	Total Assets

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Net Receivables	- 0.75	Retained Earnings
Retained Earnings	- 0.73	Total Current Liabilities
Accounts Payable	- 0.69	Retained Earnings
Other Assets	- 0.68	Short Long Term Debt Total